SCHEMBL706437

SCHEMBL706437

O=C(O)c1ccccc1Oc1ccc([N+](=O)[O-])c(F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 1/20 0.51
F10 P00742 1/20 0.50
TDP1 Q9NUW8 3/20 0.49
MEN1 O00255 1/20 0.49
TTR P02766 1/20 0.49
PPOX P50336 1/20 0.49
KMT2A Q03164 1/20 0.49
AKR1C3 P42330 4/20 0.47
AKR1C2 P52895 4/20 0.47
AKR1C1 Q04828 3/20 0.47
AKR1B1 P15121 2/20 0.47
AKR1C4 P17516 2/20 0.47
AKR1B10 O60218 1/20 0.47
ATM Q13315 1/20 0.46
PYGL P06737 4/20 0.46
PYGM P11217 3/20 0.46
HSPB1 P04792 2/20 0.43
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10784715 0.88 TDP1 (0.58) HPSEF10TDP1MEN1TTR
SCHEMBL28090366 0.84 TDP1 (0.55) HPSEF10TDP1MEN1TTR
SCHEMBL30127752 0.80 TDP1 (0.53) TDP1MEN1TTRKMT2AATM
SCHEMBL16792668 0.80 TDP1 (0.53) TDP1MEN1TTRKMT2AATM
SCHEMBL3900288 0.80 TDP1 (0.56) HPSEF10TDP1MEN1TTR
SCHEMBL3840523 0.78 HPSE (0.56) HPSETDP1KMT2AHSPB1MAPT
SCHEMBL3888921 0.78 TDP1 (0.60) HPSETDP1MEN1TTRPPOX
SCHEMBL28536955 0.78 PYGL (0.50) F10TDP1PYGLHTTTSHR
SCHEMBL17786752 0.78 ATM (0.62) TDP1MEN1KMT2AATMHSPB1
SCHEMBL4452102 0.77 KMT2A (0.55) HPSETDP1MEN1KMT2APYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112341624-B Polyimide film with low thermal expansion coefficient and production process thereof 湖南国柔科技有限公司 2022-08-02 CN disclosed
CN-112341624-A Polyimide film with low thermal expansion coefficient and production process thereof 湖南国柔科技有限公司 2021-02-09 CN disclosed
EP-1553075-B1 LPA RECEPTOR ANTAGONISTS ONO PHARMACEUTICAL CO (JP) 2013-08-14 EP disclosed
EP-2565178-A1 LPA Receptor Antagonists ONO PHARMACEUTICAL CO., LTD. (JP) 2013-03-06 EP disclosed
US-20120088782-A1 LPA RECEPTOR ANTAGONIST ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-12 US disclosed
US-8124645-B2 LPA receptor antagonist ONO PHARMACEUTICAL CO., LTD. (JP) 2012-02-28 US disclosed
US-7820682-B2 LPA receptor antagonist ONO PHARMACEUTICAL CO., LTD. (JP) 2010-10-26 US disclosed
US-20100249157-A2 LPA RECEPTOR ANTAGONIST ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-30 US disclosed
US-20080293764-A1 LPA RECEPTOR ANTAGONIST ONO PHARMACEUTICAL CO., LTD. 2008-11-27 US disclosed
US-20060148830-A1 Lpa receptor antagonist ONO PHARMACEUTICAL CO., LTD. 2006-07-06 US disclosed
EP-1553075-A1 LPA RECEPTOR ANTAGONISTS ONO PHARMACEUTICAL CO., LTD. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293764-A1 LPA RECEPTOR ANTAGONIST LPAR1, LPAR2, LPAR4 HPSE 1534/4885F10 3232/4885TDP1 3025/4885
US-20100249157-A2 LPA RECEPTOR ANTAGONIST LPAR1, LPAR2, LPAR4 HPSE 1534/4885F10 3232/4885TDP1 3025/4885
US-20120088782-A1 LPA RECEPTOR ANTAGONIST LPAR1, LPAR2, LPAR4 HPSE 1534/4885F10 3232/4885TDP1 3025/4885
US-20060148830-A1 Lpa receptor antagonist LPAR1, LPAR2, LPAR4 HPSE 1534/4885F10 3232/4885TDP1 3025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.